The remission from HIV in the “Berlin patient,” attributed to a natural Δ32 homozygous mutation in the CCR5 gene that resulted in a non-functional co-receptor, spawned the idea of CCR5 inhibition as a potential therapeutic mechanism against HIV infection. This evidence concerns the gene CCR5 and HIV infectious disease.